GENEVA, Aug. 21 -- MEDYTOX INC. filed a patent application (KR2026/002822) for “KIT FOR DETECTING ANTI-BOTULINUM TOXIN ANTIBODY AND METHOD FOR DIAGNOSING AND TREATING PATIENTS WITH SECONDARY NON-RESPONSIVENESS TO BOTULINUM TOXIN USING SAME”. With publication no. WO/2026/173467, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....